Syros Pharmaceuticals, Inc. (SYRS) SEC filings
SYRS SEC filings moved a median of -1.12% by the close. SYRS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the SYRS overview →
28 measured SYRS SEC filing events.
Where these SYRS SEC filings landedvs 28 measured SYRS SEC filing reactions
| Middle 50% of SYRS SEC filing reactions | -8.00% to +3.33% |
|---|---|
| Median reaction (to close) | -1.12% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 SYRS SEC filing events with a measured close landed between -8.00% and +3.33%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Syros Pharmaceuticals, | SEC filing · Form 15-12G | +13.70% | -10.35% | |
| Form EFFECT Syros Pharmaceuticals, | SEC filing · Form EFFECT | -9.05% | -19.81% | |
| Form 25 Syros Pharmaceuticals, | SEC filing · Form 25 | +32.93% | -9.33% | |
| Form POS AM Syros Pharmaceuticals, | SEC filing · Form POS | +32.93% | -9.33% | |
| Form S-8 POS Syros Pharmaceuticals, | SEC filing · Form S-8 | +32.93% | -9.33% | |
| Form 8-K Syros Pharmaceuticals, For: Feb 28 | SEC filing · Form 8-K | -3.41% | +1.29% | |
| Form 8-K Syros Pharmaceuticals, For: Feb 28 | SEC filing · Form 8-K | +6.79% | +13.57% | |
| Form 8-K Syros Pharmaceuticals, For: Jan 06 | SEC filing · Form 8-K | +1.51% | +6.38% | |
| Form 8-K Syros Pharmaceuticals, For: Dec 04 | SEC filing · Form 8-K | -0.09% | +3.67% | |
| Form 8-K Syros Pharmaceuticals, For: Nov 12 | SEC filing · Form 8-K | -9.26% | -23.33% | |
| Form 8-K Syros Pharmaceuticals, For: Nov 12 | SEC filing · Form 8-K | -11.21% | -9.57% | |
| Form 10-Q Syros Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -1.19% | -0.40% | |
| Form 8-K Syros Pharmaceuticals, For: Sep 04 | SEC filing · Form 8-K | +1.97% | +0.66% | |
| Form 8-K Syros Pharmaceuticals, For: Aug 12 | SEC filing · Form 8-K | +4.87% | +3.78% | |
| Form 10-Q Syros Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -0.77% | -7.55% | |
| Form S-8 Syros Pharmaceuticals, | SEC filing · Form S-8 | -0.77% | -7.55% | |
| Form 8-K Syros Pharmaceuticals, For: Jun 05 | SEC filing · Form 8-K | +0.00% | -1.91% | |
| Form 10-Q Syros Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +3.52% | +6.05% | |
| Form ARS Syros Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +0.00% | +3.21% | |
| Form DEF 14A Syros Pharmaceuticals, For: Jun 05 | SEC filing · Form DEF | +0.00% | +3.21% | |
| Form DEFA14A Syros Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | +3.21% | |
| Form PRE 14A Syros Pharmaceuticals, For: Jun 05 | SEC filing · Form PRE | +0.00% | +0.19% | |
| Form 10-K Syros Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -5.59% | -1.85% | |
| Form S-8 Syros Pharmaceuticals, | SEC filing · Form S-8 | -5.59% | -1.85% | |
| Form 8-K Syros Pharmaceuticals, For: Jan 08 | SEC filing · Form 8-K | -1.11% | -4.43% | |
| Form 8-K Syros Pharmaceuticals, For: Dec 18 | SEC filing · Form 8-K | -2.88% | -1.98% | |
| Form 8-K Syros Pharmaceuticals, For: Dec 06 | SEC filing · Form 8-K | +10.07% | +39.58% | |
| Form 10-Q Syros Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.79% | +6.67% |
Keep exploring
More SYRS: earnings → · analyst actions → · SYRS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Galectin Therapeutics Inc. (GALT) | 309 | 0.00% | 50% |
| MENLO THERAPEUTICS INC COMMON (MNLO) | 308 | 0.00% | 49% |
| Adverum Biotechnologies, Inc. (ADVM) | 306 | 0.00% | 49% |
| Establishment Labs Holdings Inc. - Common Shares (ESTA) | 306 | +0.13% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.